CleanJoule's SpaceSAF Successfully Fuels a Rotating Detonation Rocket Engine
PARIS--(BUSINESS WIRE)--In a first-of-its-kind test, CleanJoule's high-performance alternative rocket fuel, SpaceSAF, was successfully used to power a Rotating Detonation Rocket Engine (RDRE) developed by Venus Aerospace, marking a major validation of next-generation fuel compatibility with cutting-edge propulsion systems. The ground test was conducted at Venus's Houston-based test site and represents a significant step forward in expanding the operational flexibility of RDRE technology across dual use missions.
The successful detonation of an RDRE utilizing SpaceSAF proves that alternative fuels can deliver on both performance and emissions needs in commercial and defense applications.
Share
'Without affordable, domestically-produced alternative fuels, the financial and environmental costs of space missions become unsustainable,' said Mukund Karanjikar, CEO and founder, CleanJoule. "The successful detonation of an RDRE utilizing SpaceSAF proves that alternative fuels can deliver for both performance and emissions needs in commercial and defense applications.'
SpaceSAF is a drop-in replacement for liquid (RP-1 & RP-2) rocket fuels that improves mission performance including increasing payload and distance. From the same base material used to produce SpaceSAF, CleanJoule also produces a sustainable solid rocket fuel (SSRF) for use as a superior performance, drop-in replacement for existing solid rocket motors. This milestone comes at a critical time with an ecosystem emerging that is focused on expanding access to space across satellite deployment, exploration, and defense systems. As more frequent launches drive up related CO2 emissions, the need for performant alternatives to conventional rocket fuels is urgent.
'This test helps advance an important conversation in aerospace: how to pair next-gen propulsion with alternative fuels that don't compromise on performance,' said Nick Cardwell, VP of Product and Advanced Concepts, Venus Aerospace. 'CleanJoule's work on high-performance, low-emissions fuels contributes meaningfully to an evolving space and defense ecosystem, and we're pleased to see their product perform under real operational conditions.'
About CleanJoule
CleanJoule Inc., headquartered in Salt Lake City, Utah, is an advanced fuels company that enhances performance across commercial and defense aerospace. CleanJoule's breakthrough pathway produces the only full performance, 100 percent drop-in advanced fuel that can be used for commercial, military, and space applications. CleanJoule's focus is on distributed manufacturing of advanced aviation fuels using readily available domestic biomass feedstocks, further ensuring supply chain resilience. CleanJoule's manufacturing process has superior efficiency while increasing energy density and reducing carbon emissions, soot, and contrail formation. Backed by Indigo Partners, Cleanhill Partners, GenZero, Frontier Airlines, Wizz Airlines, and Volaris, CleanJoule is on a mission to create superior aerospace and defense fuels that enable domestic supply chain resiliency. For more information, visit https://cleanjoule.com/.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Wire
39 minutes ago
- Business Wire
Simulmedia and OptimizeRx Announce Partnership from the Cannes Lions
CANNES, France--(BUSINESS WIRE)-- Simulmedia, a national leader in data-driven TV and streaming advertising, today announced a strategic partnership with OptimizeRx Corp. (Nasdaq: OPRX), a leading provider of healthcare technology solutions, to enable the self-serve availability of Micro-Neighborhood ® Targeting (MNT) audiences across linear, digital, and connected TV (CTV) channels. This collaboration allows healthcare brands—especially small and mid-size pharmaceutical companies and in-house planning teams—to activate clinically precise audiences across guaranteed premium TV and streaming inventory, with the speed and flexibility of programmatic advertising. MNT audience data enables consumer targeting at the household level, based on zip-9 geographic disease prevalence mapping, for a privacy-forward approach to the incorporation of clinical data to media targeting. Unlike other data providers, OptimizeRx holds two patents for ensuring HIPAA compliance and meeting the increasingly strict privacy standards of state-by-state laws. In addition, MNT safely integrates comprehensive consumer data. Life science marketers benefit from scaled, data-driven linear TV and streaming activation and measurable brand impact. The partnership between OptimizeRx and Simulmedia allows for: Rapid deployment of data-driven linear and CTV healthcare campaigns, enabling a dynamic audience activation approach for TV Predictive spot-level TV placements based on viewing behavior within clinically focused audiences during specific periods of the care journey Real-time campaign adjustments using premium inventory, and a brand-specific, predictive clinical profile Activation of compliance-grade MNT audiences across all major TV networks (250+) and streaming platforms in a single buy Addressing Key Industry Challenges The combined technologies and data-driven approach address long-standing limitations in linear TV media buying for healthcare advertisers, including lack of audience precision, slow time-to-market, and large minimum spend thresholds. By combining OptimizeRx's healthcare data expertise with Simulmedia's reach, and predictive TV and streaming placement capabilities, healthcare media buyers can now gain full-funnel engagement with actionable reach. 'This partnership extends the reach of Micro-Neighborhood Targeting into high-impact linear TV environments,' said Steve Silvestro, Chief Executive Officer of OptimizeRx. 'It offers a scalable, clinically-driven alternative – or augmentation – to traditional 'spray-and-pray' TV campaigns—especially valuable for brands prioritizing omnichannel impact.' "Partnering with OptimizeRx gives us a powerful new lever to deliver smarter, more relevant video campaigns for healthcare brands," said Kim Jones, SVP Sales Strategy & Solutions, at Simulmedia. "Their unique blend of real-world clinical data, HIPAA-compliant targeting, and national point-of-care reach allows us to offer precision at scale—bridging the gap between audience insight and media activation. Together, we're transforming how healthcare marketers engage patients and providers across every step of the care journey." About OptimizeRx OptimizeRx provides trailblazing technology that fosters care-focused engagement between life sciences organizations, healthcare providers, and patients at critical junctures throughout the healthcare journey. With the ability to synchronize messaging across 2 million healthcare providers and over 240 million adults across a multitude of digital channels including a proprietary point-of-care network, OptimizeRx is changing the way life science companies engage with customers. For more information, follow the Company on Twitter, LinkedIn or visit About Simulmedia
Business Wire
39 minutes ago
- Business Wire
EcoVadis and Ivalua Build on Strategic Partnership to Accelerate Risk Identification in Supply Chains
PARIS & NEW YORK--(BUSINESS WIRE)-- EcoVadis, the global standard for resilient, sustainable supply chains, and Ivalua, a global leader in spend and supplier management, extend their partnership with the availability of a new integration that brings EcoVadis IQ Plus directly into Ivalua's Risk Center, expanding on the existing integration of EcoVadis Ratings into the Ivalua platform and deepening the collaboration between the two companies. Today's global supply chains place procurement teams under heightened pressure. They must navigate rising risk management costs, greater market volatility, geopolitical tensions, climate change and resource scarcity, all while facing increasing stakeholder expectations and regulatory demands. These challenges are reshaping the supplier risk management environment which is now defined by: Increasing process complexities A growing number of risks to manage (ESG, operational etc.) A proliferating network of third parties, whose risks must also be managed Expanding regulatory requirements The integration helps address these challenges for procurement teams by embedding risk signals and sustainability intelligence from EcoVadis IQ Plus into Ivalua's platform, across any workflow, so users can visualize potential risk hotspots before engaging with suppliers. By leveraging predictive analytics and global risk indicators, this seamless connection equips decision-makers with data-driven insights at the earliest stages of the sourcing and supplier management process. 'Our partnership with Ivalua is grounded in a shared commitment to embed sustainability into procurement at scale to help organizations meet growing regulatory, investor, and customer expectations,' said EcoVadis' cofounder and co-CEO Pierre-François Thaler. 'Through this new data integration, we are empowering procurement and supply chain teams to proactively identify sustainability and ESG-related risks across their supplier base, faster and more effectively than ever before.' 'By combining EcoVadis IQ Plus and Ivalua's market-leading capabilities, we enable organizations to address today's challenges and future-proof for tomorrow in a more efficient and cost-effective way,' said Franck Lheureux, CEO at Ivalua. 'It's more than just displaying scores. With Ivalua, organisations can leverage EcoVadis insights wherever they want, across any processes to make better and faster decisions to proactively manage risks and drive sustainable practices.' The new integration will allow organizations to assess third parties' ESG maturity earlier, more quickly, and across a broader range of suppliers. With these insights, organizations can enhance their supply chain risk mapping capabilities to more efficiently and effectively assess and mitigate risk through key capabilities including: Risk mapping across the entire supplier base Faster qualification and screening of new suppliers Continuous monitoring of sustainability-related risks Improved decision-making for supplier selection and risk mitigation The EcoVadis IQ Plus integration is now available to all Ivalua customers globally. Interested in learning more about how your organization can collaborate with EcoVadis and Ivalua? Visit the Ivalua website or contact EcoVadis here. ABOUT ECOVADIS EcoVadis is a purpose-driven company dedicated to embedding sustainability intelligence into every business decision worldwide. With global, trusted and actionable ratings, businesses of all sizes rely on EcoVadis' detailed insights to comply with ESG regulations, reduce GHG emissions, and improve the sustainability performance of their business and value chain across 220 industries in 185 countries. Leaders like Johnson & Johnson, L'Oréal, Unilever, Bridgestone, BASF and JPMorgan are among 150,000+ businesses that use EcoVadis ratings, risk, and carbon management tools and e-learning platform to accelerate their journey toward resilience, sustainable growth and positive impact worldwide. Learn more on: X or LinkedIn. ABOUT IVALUA Ivalua is a leading provider of cloud-based, Spend Management software powered by AI agents. Our unified Source-to-Pay platform enables businesses to better manage all categories of spend and all suppliers, increasing profitability, improving sustainability, lowering risk and boosting employee productivity. We are trusted by hundreds of the world's most admired brands and recognized as a leader by Gartner and other analysts. Learn more at Follow us on LinkedIn.
Business Wire
39 minutes ago
- Business Wire
Americhem Aligns European Region Under Global Brand
CUYAHOGA FALLS, Ohio--(BUSINESS WIRE)--Americhem Inc., a global leader in polymer solutions, has unified its European operations under the Americhem brand—streamlining customer experience and reinforcing alignment across global quality and manufacturing standards. 'This move simplifies how we scale and serve,' said CEO John Richard. 'One brand delivers clarity, consistency, and confidence.' The Denmark site supports Americhem's healthcare strategy, producing ISO 13485 compounds for hearing aids, surgical tools, and drug delivery. Clean compounding developed in North America has been replicated, with expansion planned in Asia. Key focus areas also include fibers and building products, where material durability, color precision, and speed-to-market matter most. Local teams now operate fully within Americhem's global systems. 'Customers here get the same responsiveness and quality trusted across our global network,' said Barto DuPlessis, Vice President and General Manager of Europe. The shift also advances Americhem's 2030 sustainability goals. Denmark leads with 100% renewable electricity and on-site solar, while energy-efficient technologies like ColdPound reduce usage by up to 85% compared to traditional extrusion. With this alignment, Americhem strengthens its commitment to global consistency, local excellence, and sustainable progress. About Americhem Americhem is an innovative, technology-driven leader in the global polymer industry. Its foundation is built around delivering Performance, Solutions and Trust through close collaboration with customers. All of the company's products are backed by complete technical support that ensures quality, reliability, and value. Americhem operates 10 manufacturing plants and maintains sales offices throughout the world. Americhem is owned by Pritzker Private Capital along with management and co-investors.
